BioSpace News Archive

Biotech Bay

Five Prime Therapeutics Announces Closing of Upsized Public Offering

Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Leerink Partners LLC are acting as book-running managers for the offering.

January 30, 2018
·
1 min read
Business

Amarin Announces Proposed Public Offering of American Depositary Shares

On January 26, 2018, the last sale price of the ADSs on The NASDAQ Global Market was $4.27 per share.

January 30, 2018
·
4 min read
Biotech Bay

Iovance Biotherapeutics Announces Closing of $172.5M Common Stock Public Offering

Iovance intends to use the proceeds from this offering to fund its ongoing clinical trials for its current product candidates, including its ongoing Phase 2 clinical trials of LN-144,

January 30, 2018
·
4 min read
Genetown

Albireo Announces Closing of $74.8M Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares

Cowen and William Blair acted as joint book-running managers and representatives of the underwriters for the offering.

January 30, 2018
·
2 min read
Business

University of Iowa Health Care Increases Industry-Sponsored Clinical Trial Opportunities With TriNetX

In the first six months, UI Health Care was provided access to over 40 clinical trial opportunities from biopharmaceutical companies and CROs on the network.

January 30, 2018
·
3 min read
Drug Development

Diffusion Pharmaceuticals Announces First Patient Dosed in Phase III Trial With TSC in Inoperable Glioblastoma Multiforme

The INTACT trial will compare standard of care radiation therapy and chemotherapy plus TSC against SOC alone.

January 30, 2018
·
10 min read
Pharm Country

Misonix to Report Fiscal 2018 Second Quarter Financial Results, Host Conference Call and Webcast on February 6

The Company will host a conference call and webcast at 4:30 p.m. ET that day to review the results. Both the call and webcast are open to the general public.

January 30, 2018
·
1 min read
Policy

TriNetX Achieves ISO 27001:2013 Certification

The certification reinforces TriNetX’s dedication to conducting best practices and its determination to provide the highest level of information security for its clients.

January 30, 2018
·
2 min read
Business

GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 5 February, 2018

A replay of the call will also be available through the Company’s website (www.gwpharm.com) shortly after the call.

January 30, 2018
·
1 min read
Business

Dova Pharmaceuticals Announces the Appointment of Mark W. Hahn as CFO

Mark will officially commence in his role as Chief Financial Officer of Dova on January 31st, 2018.

January 30, 2018
·
3 min read